About the Event
The Scientific Colloquium take immense pleasure in welcoming you all to the International Virtual Conference on Pharmaceutics & Drug Delivery research which is held during August 25-26, 2022 at 11:00-18:00 GMT.
Drug Delivery 2022 Webinar serve as a stage for the relationship between specialists in the space of Pharmaceutics, Drug Delivery, Drug Discovery, Nanomedicine, Biotechnology, and nanotechnology all over the planet and sight in designate a few unmistakable examination and translational investigations on different advances in the connected fields. This Pharmaceutics Conference involve a wide scope of Keynote introductions, Oral discussions, Poster introductions, Symposia, Workshops, Exhibitions and Career improvement programs.
The Drug Delivery and Nanomedicine Webinar attribute a wide scope of imaginative medication conveyance advancements that could prospect foster the conveyance of different kinds of medications, including proteins, peptides, oligonucleotides, biologics, and little atoms. It is to trade the information on state-of-the-art advances, innovative work, new therapeutics, and request in the field of drug sciences and medication conveyance.
The drug delivery market is forecast to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the projected period. Growth in this market is mainly directed by the increase frequency of chronic diseases, growth in technological advancements and biologics market, and new product launches. On the other hand, the danger of needle stick injuries and the rising pricing pressure are anticipated to ultimatum market growth in the coming years. In addition, patients’ wellness has progresses substantially with ever improving mechanization and possibilities of massive breakthroughs in this field have propelled the drug delivery industry to a new height, and also in having an astounding growth in drug delivery systems for hormones and cardiology agents. The global market for advanced drug delivery system is expected to amount for the value of $196.4 billion by 2025 at 7.2% CAGR.